Microsatellite instability (MSI-H) is associated with a high immunoscore but not with PD-L1 expression or increased survival in patients (pts.) with metastatic colorectal cancer (mCRC) treated with oxaliplatin (ox) and fluoropyrimidine (FP) with and without bevacizumab (bev): a pooled analysis of the AIO KRK 0207 and RO91 trials
Titel:
Microsatellite instability (MSI-H) is associated with a high immunoscore but not with PD-L1 expression or increased survival in patients (pts.) with metastatic colorectal cancer (mCRC) treated with oxaliplatin (ox) and fluoropyrimidine (FP) with and without bevacizumab (bev): a pooled analysis of the AIO KRK 0207 and RO91 trials
Auteur:
Noepel-Duennebacke, Stefanie Juette, Hendrik Schulmann, Karsten Graeven, Ulrich Porschen, Rainer Stoehlmacher, Jan Hegewisch-Becker, Susanna Raulf, Arne Arnold, Dirk Reinacher-Schick, Anke Tannapfel, Aandrea